Target intelligence / Profile preview

Siderophore receptor and porin proteins (TBDR/OMP)

Target
TBDR/OMP
Molecular classification
Transporter, Outer membrane protein, Beta-barrel protein
01

Overview

Siderophore receptor and porin proteins are essential outer membrane components of Gram-negative bacteria that serve as the primary gateways for nutrient acquisition and molecular entry. Siderophore receptors, primarily TonB-dependent receptors (TBDRs), facilitate the active transport of iron-siderophore complexes across the outer membrane, a process powered by the TonB-ExbB-ExbD complex in the inner membrane (PMID: 22403408). Porins are protein channels that allow the passive diffusion of small, hydrophilic molecules, including many classes of antibiotics like beta-lactams and fluoroquinolones (PMID: 12654431). These proteins are exploited by "Trojan Horse" antibiotics, such as Cefiderocol, which mimics a siderophore to be actively transported into the periplasm, thereby bypassing common resistance mechanisms like porin loss or efflux pump upregulation (PMID: 30718271). Targeting these proteins is a critical strategy for treating multi-drug resistant (MDR) infections caused by pathogens like Pseudomonas aeruginosa, Acinetobacter baumannii, and Enterobacteriaceae (PMID: 31533998). Resistance to drugs targeting these proteins often arises through the downregulation of porins or mutations in the siderophore transport machinery, presenting a significant therapeutic challenge.

Other names
TonB-dependent receptorsOuter membrane porinsIron-siderophore transportersBacterial outer membrane proteins
02

Mechanism of action

Siderophore-mediated active transport (Trojan Horse mechanism) and passive diffusion through porin channels

03

Biological functions

Iron acquisitionNutrient transportPassive diffusionOsmotic regulation
04

Disease associations

Infection
05

Safety considerations

Development of resistance via porin downregulationMutations in TonB-dependent transport systemsReduced efficacy in low-iron environments
06

Interacting drugs

Cefiderocol

1 more in the full profile.

07

Biomarkers

Porin expression (OmpC/OmpF/OmpK35/OmpK36)TonB-dependent receptor expression (Fiu/Cir/PiuA/PirA)PBP3 expression

Beyond the preview

Go deeper on Siderophore receptor and porin proteins (TBDR/OMP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Siderophore receptor and porin proteins (TBDR/OMP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call